Copy Number Variants of Uncertain Significance by Chromosome Microarray Analysis from Consecutive Pediatric Patients: Reevaluation Following Current Guidelines and Reanalysis by Genome Sequencing
Authors:
- Wenjiao LiWLWenjiao Li
- Xiaolei XieXXXiaolei Xie
- Hongyan ChaiHCHongyan Chai
- Autumn DiAdamoADAutumn DiAdamo
- Emily BistlineEBEmily Bistline
- Peining LiPLPeining Li
- Yuan DaiYDYuan Dai
- James KnightJKJames Knight
- Abraham Joseph Avni-SingerAAAbraham Joseph Avni-Singer
- Joanne BurgerJBJoanne Burger
- Laura MentLMLaura Ment
- Michele Spencer-ManzonMSMichele Spencer-Manzon
Open Access
Abstract
Background: Copy number variants of uncertain significance (CNVus) from chromosome microarray analysis (CMA) presents unresolved challenges for clinical geneticists, genetic counselors, and patients. We performed a systematic reevaluation of reported CNVus and reanalysis of selected CNVus by whole genome sequencing (WGS) to assess the diagnostic value and clinical impact on CNVus reclassification. Methods: We retrospectively reviewed 5277 consecutive pediatric cases by CMA from the Yale Clinical Cytogenetics Laboratory over a 13-year period. Reevaluation was performed on all reported CNVus following current ACMG/ClinGen guidelines. Reanalysis by WGS was applied to selected cases for reclassification of CNVus. Results: A total of 567 CNVus from 480 cases were reported, which accounted for 9.1% of pediatric cases. A total of 4 CNVus in 4 cases (0.8%, 4/480) were reclassified to pathogenic/likely pathogenic CNVs (pCNVs/lpCNVs); while 23 CNVus in 23 cases (4.8%, 23/480) were reclassified to benign/likely benign CNVs (bCNVs/lbCNVs). The overall rate of reclassification was 5.6%. WGS performed on selected cases further defined breakpoints and ruled out additional causative genetic variants. Conclusions: The results from this study demonstrated the diagnostic value of periodic reevaluation of CNVus and reanalysis by WGS in an interval of 3–5 years and provided evidence to support standardized laboratory reevaluation and reanalysis.Keywords
This publication has 44 references indexed in Scilit:
- Genotype–phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorderHuman Genetics, 2023
- Analysis of dystrophin gene in Iranian Duchenne and Becker muscular dystrophies patients and identification of a novel mutationNeurological Sciences, 2015
- Central 22q11.2 deletionsAmerican Journal of Medical Genetics Part A, 2014
- From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices PipelineCurrent Protocols in Bioinformatics, 2013
- Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literatureAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2013
- Phenotypic variability of atypical 22q11.2 deletions not includingTBX1American Journal of Medical Genetics Part A, 2012
- Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disordersAmerican Journal of Medical Genetics Part A, 2011
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesThe American Journal of Human Genetics, 2010
- Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame ruleMuscle & Nerve, 2006
- Crkl Deficiency Disrupts Fgf8 Signaling in a Mouse Model of 22q11 Deletion SyndromesDevelopmental Cell, 2006